A Study of Duloxetine in Patients With Osteoarthritis Knee Pain

Osteoarthritis Knee Pain Clinical Trial

Official title:
A Phase 3b Study to Assess the Efficacy of Duloxetine 60 mg Once Daily Compared With Placebo on the Reduction of Pain Caused by Osteoarthritis of the Knee, in a 13-week, Double-blind, Randomized Study

Status Completed

Clinical Trial Summary

The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00945945
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	July 2009
Completion date	May 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01018680` - A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis	Phase 3
Completed	`NCT00790790` - A Study in the Treatment of Osteoarthritis Knee Pain	Phase 2
Completed	`NCT00408421` - Duloxetine Versus Placebo for Osteoarthritis Knee Pain	Phase 3
Completed	`NCT03434197` - Safety and Efficacy of SFPP in Knee Osteoarthritis	Phase 3
Completed	`NCT00433290` - Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain	Phase 3